The US FDA has approved
Vonvendi, von Willebrand factor
(recombinant) for use in the
treatment and control of bleeding
episodes in adults 18 years of age
and older who have von Willebrand
disease.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Dec 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Dec 15
FORMER Pharmacy Board of Australia Chairman, retired Colonel Bill Kelly, was one of five pharmacists recognised in the 2021 Australia Day Honours List.
ONGOING medicines supply shortages are not going to go away without strong leadership and collaboration between pharmacists, prescribers and regulators, Pharmacy Guild of Australia Victorian Branch President, Anthony Tassone, believes.
PHARMACISTS may not be set to administer the recently approved Pfizer BioNTECH COVID-19 vaccine, but the profession will be vital to its successful rollout, Pharmaceutical Society of Australia (PSA) National President, Associate Professor Chris Freeman believes.
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.